TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RPRX

Royalty Pharma Plc

Healthcare · Biotechnology

57.20$ -0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Royalty Pharma Plc (RPRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 19,820 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RPRX
Line item Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
33 27 21 16 13 11 8.8 5.4 5.9 3.8 – – – 12,450 13,372 15,686 21,338 21,097 15,914 16,515 17,732 17,516 17,379 17,740 17,673 16,813 17,074 17,121 15,856 16,382 16,131 17,657 18,042 18,223 17,608 18,323 19,347 19,621 19,815 19,820
– – – – – – 8.8 4.5 5.0 2.9 1,943 – – 832 1,738 3,391 2,784 2,697 2,416 2,707 2,776 2,878 2,982 3,504 2,342 2,555 2,631 2,954 1,729 1,274 1,560 2,579 1,794 1,802 1,843 1,520 1,850 619 1,426 812
32 26 21 16 13 11 8.7 3.2 3.8 1.8 -1,943 – – 246 624 2,443 1,553 1,009 709 1,142 1,801 1,541 1,792 2,108 992 1,711 1,976 2,173 936 477 843 1,765 950 929 1,088 632 939 619 586 812
– – – – – – – – – – 1,943 – – 793 1,696 3,343 2,133 1,992 2,369 2,651 2,693 2,803 2,911 3,401 2,217 2,428 2,588 2,908 1,684 1,234 1,532 2,553 1,764 1,771 1,816 1,488 955 637 608 837
– – – – – – – – – – – – – 39 42 35 37 39 40 45 74 68 66 35 35 37 38 35 38 22 22 24 25 27 24 28 889 884 807 889
– – – – – – – – – – – – – – – – 600 657 0.0 – – 0.0 – – 0.0 0.0 0.0 0.0 – – – – -791 – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 0.0 – 925 925 925 925 924
– – – – – – – – – – – – – 52 46 40 34 29 23 17 11 5.7 – – – 15 14 17 16 1.8 – 5.3 14,968 – – 15,134 5.3 – 16,542 –
2.9 2.5 2.9 2.1 2.3 2.3 2.7 3.8 6.2 5.1 – – – 6,308 6,209 6,291 6,192 6,124 6,077 6,110 7,346 7,267 7,237 7,332 7,256 7,288 7,252 7,308 6,270 6,298 6,267 7,905 7,784 7,880 7,820 8,820 9,726 9,906 9,879 10,034
2.9 2.5 2.9 2.1 2.3 2.3 2.7 2.8 2.7 2.4 – – – 333 434 451 270 308 256 284 255 171 136 182 1,132 1,167 1,117 1,172 128 161 125 276 1,168 1,254 1,183 1,207 531 636 536 631
– – – – – – – – – – – – – 282 182 182 199 182 249 69 6,902 6,892 – – 997 998 998 999 – – – – 997 998 999 999 383 380 380 380
2.2 1.8 2.0 1.6 1.6 1.8 1.9 1.7 1.5 1.2 – – – 11 21 34 24 11 8.3 9.4 9.2 5.6 6.7 12 16 7.9 6.7 5.8 14 15 12 23 22 13 38 20 41 19 25 36
– – – – – – – – – – – – – 5,956 5,775 5,730 5,812 5,817 5,821 5,826 7,091 7,096 7,101 7,106 6,115 6,119 6,123 6,127 6,131 6,135 6,139 7,602 6,610 6,615 6,619 7,003 8,566 8,571 8,576 8,582
30 24 19 14 10 8.4 6.1 1.6 -0.3 -1.3 4,552 – – 6,106 5,160 4,157 9,799 9,896 4,882 5,734 5,793 5,777 5,778 6,027 6,152 5,628 5,954 6,282 6,139 6,526 6,500 6,476 6,870 6,947 6,689 6,348 6,414 6,477 6,889 6,833
– – – – – – -320 -325 -328 -329 – – – 2,825 2,562 1,571 1,807 1,921 1,924 2,292 2,321 2,255 2,225 2,446 2,505 1,965 2,217 2,253 2,135 2,518 2,427 2,378 2,765 2,846 2,481 2,223 2,304 2,356 2,507 2,459
249 249 249 249 249 249 249 269 275 323 354 354 354 352 351 354 370 388 607 607 607 607 607 607 607 523 607 606 601 602 597 597 593 589 578 562 560 560 560 557

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?